| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |